Insider trades
Alastair Garfield, Chief Officer of Rhythm Pharmaceuticals RYTM, has filed 0 purchases and 2 sales on the open market. The latest trade was on 02/11.
Alastair Garfield
Chief Scientific Officer
- Company
- Rhythm Pharmaceuticals RYTM
- First filing
- 24/07/10
- Trades
- 13 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- No record
- Last trade
- 02/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RYTM | Open-market sale10b5-1 plan | 25/07/02 | 25/07/03 | 1,319 sh2 trades | $64.81avg. | $85,483.13 | −29.7% |